CureVac NV

Market Cap: Small Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: NL0015436031

USD

5.12

0.01 (0.2%)

Dec 04

NAS

Click here to see other stocks

Company CV

About CureVac NV

stock-summary

CureVac NV

Pharmaceuticals & Biotechnology

CureVac AG is a Germany-based biotechnology company. The Company is engaged in the therapeutic development of messenger Ribonucleic Acid (mRNA) and RNA-based vaccines. CureVac AG focuses on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. The Company's pipeline focuses on three areas: cancer immunotherapy, prophylactic vaccines, and protein-based therapies.

Company Coordinates

Company Details

Friedrich-Miescher-Str. 15 , TUEBINGEN None : 72076

stock-summary

Tel: 49 7071 98830

stock-summary

stock-summary

Registrar Details

Shareholding

Shareholding Snapshot

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Domestic Funds

Held in 17 Schemes (2.31%)

Foreign Institutions

Held by 79 Foreign Institutions (2.08%)

Strategic Entities with highest holding

Highest Public shareholder

Board of Directors

Management

Designation

No Data

Stock DNA

Revenue and Profits:

Net Sales:

1 Million

(Quarterly Results - Mar 2025)

Net Profit:

-55 Million

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 1,205 Million (Small Cap)

P/E

5.00

Industry P/E

NA

Dividend Yield

0.00%

Debt Equity

-0.67

Return on Equity

29.24%

Price to Book

1.72